Product Portfolio

RHEI’s current product portfolio includes branded pharmaceuticals: cardio-metabolic, neurology, oncology and dermatology. RHEI continually seeks late stage product opportunities to in-license.

Ethical Division Indication Licensor
Asacard® - A controlled release formulation of aspirin Cardio-Metabolic Flamel Technologies
Attental™ - A natural product used to treat ADHD Neurology MethaPharma
MuGard™ - A proprietary oral rinse product for the prevention and treatment of oral mucositis Oncology Access Pharmaceuticals
Tibozole™ (Miconazole nitrate 10 mg muco-adhesive buccal tablet) - Innovative once daily oral treatment of oro-pharyngeal candidiasis Oncology/Antiviral Tibotec (a J&J Company)
Pharmacy Division Indication Licensor
Drs. Hans Schreuder Vision for Health Skin Care - Seven products that give the skin the very best natural and healthy nutrition Dermatology Drs. Hans Schreuder Products BV